QA: Insys Therapeutics Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516479_2014_Insys_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001516479, Insys Therapeutics Inc

  xvar xval
0 AssetsCurrent 82,150,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,127,000
3 remainder_Assets 8,281,000
4 LiabilitiesCurrent 21,081,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 12,665,000
8 SellingGeneralAndAdministrativeExpense 16,372,000
9 ResearchAndDevelopmentExpense 8,499,000
10 remainder_Expenses 20,394,000
11 remainder_Revenues 99,289,000
12 remainder_NetIncome -982,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 100,558,000
1 Liabilities 21,081,000
2 Expenses 57,930,000
3 Revenues 99,289,000
4 StockholdersEquity 79,477,000
5 NetIncome 40,377,000
6 ComprehensiveNetIncome 40,377,000
7 BaseVar 139,920,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.51
9 EconomicCapitalRatio 4.04

Edgar->Model Mapping

Feature Distribution